These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 7095856)

  • 21. Antibodies (IgG) to lipopolysaccharide of Vibrio cholerae O1 mediate protection through inhibition of intestinal adherence and colonisation in a mouse model.
    Mukhopadhyay S; Nandi B; Ghose AC
    FEMS Microbiol Lett; 2000 Apr; 185(1):29-35. PubMed ID: 10731603
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunogenicity and protective efficacy of Vibrio cholerae outer membrane vesicles in rabbit model.
    Roy N; Barman S; Ghosh A; Pal A; Chakraborty K; Das SS; Saha DR; Yamasaki S; Koley H
    FEMS Immunol Med Microbiol; 2010 Oct; 60(1):18-27. PubMed ID: 20528929
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Secretory antibodies to homologous and heterologous strains of staphylococci in rabbit colostrum].
    Verrshigora AE; Ovod VV
    Zh Mikrobiol Epidemiol Immunobiol; 1980 Oct; (10):88-90. PubMed ID: 7445844
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunogenicity and protective role of an IgA reactive 31-kDa antigen of Vibrio cholerae O139.
    Kumar S; Ray P; Singh H; Ganguly NK
    J Med Microbiol; 2001 Jun; 50(6):489-498. PubMed ID: 11393286
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cell-bound haemagglutinin (CHA) of V. cholerae 01 as protective antigen.
    Chaicumpa W; Boonthum A; Kalumbaheti T; Tapchaisri P
    Southeast Asian J Trop Med Public Health; 1984 Sep; 15(3):407-13. PubMed ID: 6523176
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of some antigenically related outer-membrane proteins of strains of Vibrio cholerae O1 and non-O1 serovars involved in intestinal adhesion and the protective role of antibodies to them.
    Sengupta D; Datta-Roy K; Banerjee K; Ghose AC
    J Med Microbiol; 1989 May; 29(1):33-9. PubMed ID: 2724325
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immune mechanisms and protective antigens of Vibrio cholerae serogroup O139 as a basis for vaccine development.
    Jonson G; Osek J; Svennerholm AM; Holmgren J
    Infect Immun; 1996 Sep; 64(9):3778-85. PubMed ID: 8751929
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Naturally occurring secretory immunoglobulin A antibodies to Streptococcus mutans in human colostrum and saliva.
    Arnold RR; Mestecky J; McGhee JR
    Infect Immun; 1976 Aug; 14(2):355-62. PubMed ID: 971950
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum antibacterial and antitoxin responses in clinical cholera caused by Vibrio cholerae O139 Bengal and evaluation of their importance in protection.
    Nandy RK; Albert MJ; Ghose AC
    Vaccine; 1996 Aug; 14(12):1137-42. PubMed ID: 8911010
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunoglobulin A and secretory immunoglobulin A antibodies to purified type 1 Klebsiella pneumoniae pili in human colostrum.
    Davis CP; Houston CW; Fader RC; Goldblum RM; Weaver EA; Goldman AS
    Infect Immun; 1982 Nov; 38(2):496-501. PubMed ID: 6128305
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effect of Vibrio cholerae toxoid on the levels of antibodies of the IgG, IgA and IgM classes in rabbits].
    Aleksandrowicz J; Kudelski Z
    Med Dosw Mikrobiol; 1986; 38(1):15-22. PubMed ID: 3713366
    [No Abstract]   [Full Text] [Related]  

  • 32. Immunogenicity of Vibrio cholerae O1 fimbriae in animal and human cholera.
    Ehara M; Ichinose Y; Iwami M; Utsunomiya A; Shimodori S; Kangethe SK; Neves BC; Supawat K; Nakamura S
    Microbiol Immunol; 1993; 37(9):679-88. PubMed ID: 7505875
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rapid effects of a protective O-polysaccharide-specific monoclonal IgA on Vibrio cholerae agglutination, motility, and surface morphology.
    Levinson KJ; De Jesus M; Mantis NJ
    Infect Immun; 2015 Apr; 83(4):1674-83. PubMed ID: 25667263
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Seroepidemiological studies of El Tor cholera in Bangladesh: association of serum antibody levels with protection.
    Glass RI; Svennerholm AM; Khan MR; Huda S; Huq MI; Holmgren J
    J Infect Dis; 1985 Feb; 151(2):236-42. PubMed ID: 3968450
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Animal models for immunoglobulin A secretion.
    Keren DF; Suckow MA
    Methods Enzymol; 1994; 235():140-55. PubMed ID: 8057892
    [No Abstract]   [Full Text] [Related]  

  • 36. Evaluation of different subcellular fractions of Vibrio cholerae O139 in protection to challenge in experimental cholera.
    Bondre VP; Sinha VB; Srivastava BS
    FEMS Immunol Med Microbiol; 1997 Dec; 19(4):323-9. PubMed ID: 9537758
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enzyme-linked immunoassays for antibodies against Vibrio cholerae.
    Cooper GN; McNab CE; Jackson GD; Walker P
    Aust J Exp Biol Med Sci; 1983 Dec; 61 ( Pt 6)():713-25. PubMed ID: 6426450
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cholera toxin modulates the systemic immune responses against Vibrio cholerae surface antigens after repeated inoculations.
    Fernandez-Miyakawa ME; Brero ML; Mateo NA
    Microbiol Immunol; 2006; 50(8):607-19. PubMed ID: 16924145
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antibodies to outer membrane proteins of Vibrio cholerae induce protection by inhibition of intestinal colonization of vibrios.
    Sengupta DK; Sengupta TK; Ghose AC
    FEMS Microbiol Immunol; 1992 Jul; 4(5):261-6. PubMed ID: 1515155
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prophylactic significance of the nonlipopolysaccharide antigens of Vibrio cholerae.
    Attridge SR; Rowley D
    J Infect Dis; 1983 Nov; 148(5):931-9. PubMed ID: 6195273
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.